HKEX Stock Code: 01093English|繁體|简体

Highlight - 2024 Results

Revenue
RMB29,009M, -7.8%
Underlying profit attributable to shareholders
RMB4,683M, -25.4%
Reported profit attributable to shareholders
RMB4,328M, -26.3%
Basic earnings per share (reported)
RMB39.90 cents, -24.5%
Basic earnings per share (underlying profit)
RMB36.87 cents, -25.5%

Key Products

Finished drugs
Bulk drugs
© Copyright 2025 CSPC Pharmaceutical Group Limited. All Rights Reserved.